Abstract
Antimicrobial resistance (AMR) is a growing public health threat, estimatedto cause over 10 million deaths per year and cost the global economy 100trillion USD by 2050 under status quo projections. These losses would mainlyresult from an increase in the morbidity and mortality from treatment failure,AMR infections during medical procedures, and a loss of quality of lifeattributed to AMR. Numerous interventions have been proposed to control thedevelopment of AMR and mitigate the risks posed by its spread. This paperreviews key aspects of bacterial AMR management and control which makeessential use of data technologies such as artificial intelligence, machinelearning, and mathematical and statistical modelling, fields that have seenrapid developments in this century. Although data technologies have become anintegral part of biomedical research, their impact on AMR management hasremained modest. We outline the use of data technologies to combat AMR,detailing recent advancements in four complementary categories: surveillance,prevention, diagnosis, and treatment. We provide an overview on current AMRcontrol approaches using data technologies within biomedical research, clinicalpractice, and in the "One Health" context. We discuss the potential impact andchallenges wider implementation of data technologies is facing in high-incomeas well as in low- and middle-income countries, and recommend concrete actionsneeded to allow these technologies to be more readily integrated within thehealthcare and public health sectors.